Primary |
Conjunctivitis |
16.9% |
Prostatitis |
10.8% |
Local Anaesthesia |
9.2% |
Tuberculosis |
7.7% |
Cataract Operation |
6.2% |
Drug Use For Unknown Indication |
6.2% |
Eye Infection |
6.2% |
Eye Operation |
4.6% |
Pyrexia |
4.6% |
Diarrhoea |
3.1% |
Eye Inflammation |
3.1% |
Hypertension |
3.1% |
Infection Prophylaxis |
3.1% |
Meningitis |
3.1% |
Nephritic Syndrome |
3.1% |
Postoperative Care |
3.1% |
Acne |
1.5% |
Anaesthesia |
1.5% |
Bronchitis |
1.5% |
Conjunctivitis Bacterial |
1.5% |
|
Aplastic Anaemia |
14.3% |
Visual Acuity Reduced |
11.4% |
Eye Swelling |
8.6% |
Hepatitis |
8.6% |
Thrombocytopenia |
8.6% |
Pancytopenia |
5.7% |
Prostatitis |
5.7% |
Anaphylactic Reaction |
2.9% |
Blood Disorder |
2.9% |
Bone Marrow Failure |
2.9% |
Drug Interaction |
2.9% |
Embolic Stroke |
2.9% |
Eye Irritation |
2.9% |
Eye Pain |
2.9% |
Haemoptysis |
2.9% |
Hepatitis Acute |
2.9% |
Hypersensitivity |
2.9% |
Myelodysplastic Syndrome |
2.9% |
Non-infectious Endophthalmitis |
2.9% |
Ocular Hyperaemia |
2.9% |
|
Secondary |
Preoperative Care |
17.7% |
Product Used For Unknown Indication |
12.4% |
Anaesthesia |
9.5% |
Postoperative Care |
9.5% |
Cataract Operation |
7.2% |
Drug Use For Unknown Indication |
7.0% |
Antibiotic Prophylaxis |
5.5% |
Local Anaesthesia |
4.0% |
Prophylaxis |
3.2% |
Pseudomonas Infection |
3.0% |
Diarrhoea |
2.5% |
Hypertension |
2.5% |
Keratitis |
2.5% |
Uveitis |
2.5% |
Lymphocytic Leukaemia |
2.2% |
Corneal Abrasion |
2.0% |
Joint Injury |
2.0% |
Ocular Hyperaemia |
2.0% |
Post Procedural Complication |
1.5% |
Pyrexia |
1.5% |
|
Visual Acuity Reduced |
23.1% |
Endophthalmitis |
15.4% |
Toxic Anterior Segment Syndrome |
10.3% |
Anaemia |
5.1% |
Parophthalmia |
5.1% |
Thrombocytopenia |
5.1% |
Dizziness |
3.8% |
Hepatitis |
3.8% |
Ulcerative Keratitis |
3.8% |
Corneal Oedema |
2.6% |
Intraocular Pressure Increased |
2.6% |
Mucoepidermoid Carcinoma |
2.6% |
Ocular Toxicity |
2.6% |
Post Procedural Complication |
2.6% |
Sepsis |
2.6% |
Small For Dates Baby |
2.6% |
Staphylococcal Infection |
2.6% |
Anterior Chamber Disorder |
1.3% |
Aplasia Pure Red Cell |
1.3% |
Aplastic Anaemia |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
34.2% |
Drug Use For Unknown Indication |
24.7% |
Diffuse Large B-cell Lymphoma |
5.7% |
Hypertension |
4.1% |
Prophylaxis |
3.9% |
Rheumatoid Arthritis |
3.7% |
Ill-defined Disorder |
3.2% |
Retinal Haemorrhage |
2.2% |
Epilepsy |
2.0% |
Hepatic Neoplasm Malignant |
2.0% |
Constipation |
1.9% |
Diarrhoea |
1.7% |
Infection |
1.7% |
Nausea |
1.6% |
Local Anaesthesia |
1.5% |
Oesophageal Carcinoma |
1.3% |
Rash |
1.3% |
Drug Exposure During Pregnancy |
1.2% |
Cough |
1.1% |
Eye Infection |
1.1% |
|
Premature Labour |
15.8% |
Visual Acuity Reduced |
11.0% |
Sepsis |
6.8% |
Vomiting |
6.2% |
Pyrexia |
5.5% |
Intraocular Pressure Increased |
4.8% |
Rash |
4.1% |
Tachycardia |
4.1% |
Thrombocytopenia |
4.1% |
Toxic Anterior Segment Syndrome |
4.1% |
Ventricular Septal Defect |
4.1% |
Hepatitis |
3.4% |
Hyponatraemia |
3.4% |
Keratopathy |
3.4% |
Pernicious Anaemia |
3.4% |
Stevens-johnson Syndrome |
3.4% |
Syncope |
3.4% |
Urinary Tract Infection |
3.4% |
Death |
2.7% |
Gastric Perforation |
2.7% |
|
Interacting |
Cns Ventriculitis |
26.7% |
Aspergillosis |
13.3% |
Ependymitis |
13.3% |
Fungus Serology Test |
13.3% |
Product Used For Unknown Indication |
13.3% |
Atrial Fibrillation |
6.7% |
Convulsion |
6.7% |
Drug Use For Unknown Indication |
6.7% |
|
Potentiating Drug Interaction |
40.0% |
Grand Mal Convulsion |
20.0% |
Hypersensitivity |
20.0% |
Visual Acuity Reduced |
20.0% |
|